Avigen Ltd vs Nexus BioQuest

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/avigen/nexus-bioquest

Category	Avigen Ltd	Nexus BioQuest
Listed site	cro	cro
Summary	Avigen offers avidity-based profiling of live immune–target cell interactions for immunotherapy discovery and preclinical validation. Its platform supports TCR-T, CAR-T, and NK programmes across solid tumour indications.	Nexus BioQuest is an immunology-focused CRO providing preclinical drug discovery and bespoke assay design services using human primary cells and patient material to support immune-therapeutic development across oncology, autoimmunity, and inflammation.
Services	Discovery Research Preclinical In Vitro Studies	Discovery Research Translational Research Immunology & Inflammation Services Biomarker Assays In Vitro Pharmacology Preclinical In Vitro Studies
Modalities	Cell Therapy	Biologics (Monoclonal Antibodies) Biologics (Other)
Indications	Oncology	Oncology Immunology Neurology
Locations	White City (Scale Space), London, United Kingdom	Headquarters, London, England, United Kingdom
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.